Oorja Bio

Company

Oorja Bio develops one asset, in phase 2 (ORJ-001 in idiopathic pulmonary fibrosis). Mostly other.

1
Asset
Furthest stage
Phase 2
1
Trial
2
Signals

Pipeline

1
  • ORJ-001

    Phase 2, Other, idiopathic pulmonary fibrosis

Full company profiles: pipeline, trials, funding and people.

See Pro

In the full profile

  • Trials1
  • Signals2
  • Similar companies6

Intelligence